Advisory Board and Editors Immunology
Luke O'Neill
Chair of Biochemistry at Trinity College Dublin & Academic Director of the Trinity Biomedical Sciences Institute. Awards include the Royal Irish Academy Medal for Biochemistry, The Irish Society for Immunology medal, the Royal Dublin Society/Irish Times Boyle medal for Scientific Excellence & the Science Foundation Ireland Researcher of the Year Award. Co-founder and director of Opsona Therapeutics. In 2008 he was appointed Chair of the Immunity & Infection panel of the European Research Council
Masahiro Ono
Dr Masahiro Ono was originally trained as a dermatologist, and later specialised in immunology. He obtained his PhD in 2006 by a study on regulatory T cells (Treg), and later identified the interaction of the Treg-specific transcription factor Foxp3 and the transcription factor Runx1. In 2009, he obtained a HFSP Fellowship, and joined University College London (UCL), when he established a new genomic analysis tool using a multidimensional method, Canonical Correspondence Analysis (CCA). In 2012, he was awarded a BBSRC David Phillips Fellowship, and established his lab in UCL. In 2015, he moved in the Department of Life Sciences, Imperial, and was appointed as Senior Lecturer in 2018.
Recently, the Ono group has established a novel tool for analysing temporal dynamics of cellular differentiation and activation in vivo, Timer-of-Cell-Kinetics-and-Activity (Tocky とき), and his group is using this tool to investigate mechanisms underlying T cell differentiation and T cell-mediated immune response.
Anup Singh Pathania
Dr. Anup Pathania is an Assistant Professor at the University of Nebraska Medical Center (UNMC).
His research interests include non-coding RNAs in cancer, pharmacology, and immunology. He is currently investigating the underlying mechanisms in the stabilization of PD-L1 by exosomal non-coding RNAs in neuroblastoma cells within the tumor microenvironment.
George N. Pavlakis
MD, University of Athens, Greece
PhD, Syracuse University, NY
Chief of the Human Retrovirus Section of the National Cancer Institute, USA
Interests: HIV pathogenesis, Molecular Biology, gene regulation, Biotechnology, protein engineering, cytokines, Immunotherapy, Vaccines, Nucleic acid vaccines, gene therapy
Antonella Prisco
Senior Researcher at the Institute of Genetics and Biophysics of the National Research Council.
Carlo Ennio Pucillo
Carlo Pucillo is a Full Professor in Immunology at the School of Medicine of the University of Udine.
In his scientific career Prof. Carlo Pucillo has studied the "non canonical function" of MHC class II and the molecular mechanism that regulate the B cell activation and differentiation. From 2-1991 to 6-1994 Dr Pucillo has been Visiting Scientist at NCI in Bethesda, MD-USA.
He has acquired a considerable expertise in advanced molecular biology analysis as well as a good understanding of the immunobiology of the immune response, of the non canonical function of MHC class II molecules, in particular, as documented by his publications on this subjects.
He has also investigated the signal transduction pathways elicited by T-B cell interaction via CD40-CD154. CD40 is a B cell surface receptor that belongs to the pleiotropic tumor necrosis factor receptor (TNFR) superfamily. The interaction between CD40 and its ligand promotes proliferation, cytokine production, upregulation of various surface molecules involved in antigen presentation, germinal center and memory B cell formation antibody isotype switching and affinity maturation and the B cell life span.
Most recently, his interest is in the study of regulatory role of Mast Cells in the microenvironment and subsequently in the tissutal tolerance and adaptive immune response. This body of work may provide a conceptual framework to therapeutically manipulate these responses in the settings of autoimmune disease and cancer.
Jiangjiang Qin
Dr. Jiangjiang Qin is currently a Professor of Cancer Pharmacology and Drug Discovery at the Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences and the Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital).
Dr. Qin received his B.S. degree in Pharmacy (2006) and Ph.D. in Biomedical Engineering with the highest honor (2011) from Shanghai Jiao Tong University, China, under the supervision of Professor Wei-Dong Zhang. After completion of Post-Doctoral training in cancer biology, pharmacology, and molecular therapeutics at Texas Tech University Health Sciences Center (TTUHSC) in 2014, Dr. Qin continued his research work at TTUHSC as a Research Associate and a Senior Research Associate and at the University of Houston as a Senior Research Scientist. Dr. Qin joined Zhejiang Chinese Medicinal University as a Full Professor in 2018 and then moved to IBMC in 2020.
Dr. Qin’s research mainly focuses on the discovery and development of novel, effective, and safe anticancer agents as well as demonstrating the molecular targets and mechanisms of action. He has published more than 150 research papers and reviews. He is also an Associate Editor of Frontiers in Pharmacology and Frontiers in Oncology and an Editorial Board Member of more than 10 scientific journals such as Recent Patents on Anti-Cancer Drug Discovery, Journal of Cancer Research Updates, World Journal of Traditional Chinese Medicine.
Priya Ramesh Prabhu
Priya Ramesh Prabhu is a Postdoctoral research fellow in the Human Biology Division at Fred Hutchinson Cancer Center, Seattle, WA. She is an immunologist with focus on Human papillomavirus (HPV) vaccination. Her expertise is in evaluation of vaccine-induced immune responses. She completed her PhD from Rajiv Gandhi Center for Biotechnology, Kerala, India, working in a Phase IV clinical trial comparing the efficacy of 2 vs 3 doses of quadrivalent HPV vaccine among Indian girls.
Tanu Rana
Dr. Tanu Rana has a Ph.D. in Microbiology from AIIMS, New Delhi and a Master’s degree in biotechnology. Her research pursuits have spanned multiple facets of life sciences, from research on host-pathogen interaction to directing and collaborative research through a microscopy core facility.
Over the course of her career, Dr. Rana has published widely in peer-reviewed journals and presented her findings at national and international conferences, contributing meaningful insights to the fields of infectious diseases, and novel diagnostic approaches.
Beyond lab research, Dr. Rana is committed to the development of the next generation of healthcare professionals and scientists. She has taught and continues to teach medical, dental, master’s and graduate students, offering lectures, active learning opportunities, hands-on laboratory instruction, and mentorship that bridges theoretical knowledge and practical skills.
Pamela C Ronald
Professor, Dept Plant Pathology and the Genome Center, UC Davis. Director, Grass Genetics, JBEI. Fellow of the American Association for the Advancement of Science. Recipient of the USDA 2008 National Research Initiative Discovery Award. 2009 recipient of the National Association of Science Writers Science in Society Journalism Award. Selected as one of the 100 most creative people in business by Fast Company Magazine. Co-author of Tomorrow's Table: Organic Farming, Genetics, & the Future of Food
Camillo Rosano
A physicist; in 1996 Camillo Rosano started his studies in Macromolecular Crystallography at the Advanced Biotechnology Center, Genova (I). In 1997 he achieved the Advanced Certificate in Principles of Protein Structures (PPS), Birkbeck College, University of London, UK, and in 1998 he spent a period at the “York Structural Biology Laboratory” York University, York, UK for a Macromolecular crystallography traineeship. He participated to the NASA expeditions STS100/ISS6A and STS110/ISS7A by designing experiment of protein crystallization on-board the International Space Station (ISS). Director of different Courses and Workshops, he is the author/coauthor of more than 100 peer-reviewed scientific publications.
Dr. Rosano is a Full Professor in Biochemistry and Full Professor in Applied Biology. Italian Ministry for University, Education and Research (MIUR), 2012.